Cryo-Cell International (CCEL) Stock: Buy, Sell, or Hold?
CCEL - Cryo-Cell International Inc.
$4.40
0.28 (6.80%)
▲
5d:
+3.77%
30d:
+13.4%
90d:
+21.16%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Oct 21, 2026
Get Alerted When CCEL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: CCEL shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: CCEL shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: CCEL is currently trading at $4.40, which is considered extended relative to its 30-day fair value range of $3.73 to $4.31. From a valuation perspective, the stock is trading at a premium (Forward PE: 220.0) compared to its historical average (182.6). At these levels, the market is pricing in 6.4% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CCEL is in a uptrend. Immediate support is located at $4.00, while resistance sits at $4.58. The stock is showing strong short-term momentum, up 6.8% recently.
Market Sentiment: CCEL scores 34/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $8.50 (+93.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CCEL is in a uptrend. Immediate support is located at $4.00, while resistance sits at $4.58. The stock is showing strong short-term momentum, up 6.8% recently.
Market Sentiment: CCEL scores 34/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $8.50 (+93.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$3.73 -
$4.31
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
32.4%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (34/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.8%)
- BULLISH: Trading 93.2% below Wall St target ($8.50)
- NEUTRAL: Trading at premium valuation - market expects 6.4% growth which is achievable
- WARNING: Composite score 45/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$3.73 -
$4.31
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$4.00
Resistance Level
$4.58
Current Trend
Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
220.00
Wall Street Target
$8.50
(+93.2%)
Revenue Growth (YoY)
-1.9%
Earnings Growth (YoY)
72.1%
Profit Margin
-7.9%
Valuation Premium vs History
+6.4% premium
PE vs Historical
220.0 vs 182.6
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+6.4%
(market-implied from PE analysis)
1-Year Target
$4.68
(+6%)
2-Year Target
$4.98
(+13%)
3-Year Target
$5.30
(+21%)
3-Yr Target (if PE normalizes)
(PE: 220→183)
PE COMPRESSION
$4.40
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 220.0, Growth: -81.8%)
$3.21
(+-27%)
Base:
(SPY PE: 20.2, Growth: -81.8%)
$0.29
(-93%)
Bear:
(PE: 17.1, Growth: -81.8%)
$0.25
(-94%)
Share & Embed Analysis
Last updated: September 12, 2026 10:53 AM ET
Data refreshes hourly during market hours. Next update: 11:53 AM
Data refreshes hourly during market hours. Next update: 11:53 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CCEL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$285 | 61 BUY |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$451 | 50 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$148 | 55 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 52 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$135 | 56 HOLD |
